Cardio-Oncology

译名:心脏肿瘤学

ESCIJCR Q2

3-5

2026

影响因子区间

平台估算

投稿周期

13%

2025

中国作者发文占比

2490 EUR;2890 USD;2090 GBP

费用说明

收费

期刊简介:As the first journal devoted exclusively to this emerging field, Cardio-Oncology fills a critical gap in the science and clinical practice of this important field, providing an international forum for the latest findings and reviews. Whilst cancer treatments bring hope to patients with diseases once thought to be incurable, the same treatments can also harm the cardiovascular system. The journal serves as essential reading for researchers, drug developers, adult and pediatric oncologists and hematologists, cardiologists, radiation oncologists, radiologists, anesthesiologists, surgical oncologists, pediatricians, internists, geneticists, epidemiologists, and more. Cardio-Oncology is proudly affiliated with the International Cardio-Oncology Society (ICOS).

【译文】作为第一份专门致力于这一新兴领域的期刊,《心脏肿瘤学》填补了这一重要领域的科学和临床实践的关键空白,为最新发现和评论提供了一个国际论坛。虽然癌症治疗为曾经被认为无法治愈的疾病患者带来了希望,但同样的治疗也会损害心血管系统。该杂志是研究人员、药物开发商、成人和儿科肿瘤学家和血液学家、心脏病学家、放射肿瘤学家、放射科医生、麻醉师、外科肿瘤学家、儿科医生、内科医生、遗传学家、流行病学家等的必备读物。心脏肿瘤学自豪地隶属于国际心脏肿瘤学会 (ICOS)。

出版社
BioMed Central
语言
English
学科
医学
ISSN
2057-3804
eISSN
2057-3804
出版频率
年刊
创刊年份
1979
投稿网址
https://cardiooncologyjournal.biomedcentral.com/
最近更新
2026-04-02 18:16:40
Cardio-Oncology

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间3-5
暂无